Exploring the benefits and limits of highly active antiretroviral therapy
- PMID: 10553795
- DOI: 10.1001/jama.282.17.1668
Exploring the benefits and limits of highly active antiretroviral therapy
Comment on
-
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy.JAMA. 1999 Nov 3;282(17):1627-32. doi: 10.1001/jama.282.17.1627. JAMA. 1999. PMID: 10553788
-
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.JAMA. 1999 Nov 3;282(17):1633-7. doi: 10.1001/jama.282.17.1633. JAMA. 1999. PMID: 10553789 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical